~~<i id='526CA9E424'><strike id='526CA9E424'><tt id='526CA9E424'><pre id='526CA9E424'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：focus 2025-09-05 11:31:57 - browse：7

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： The biotech scorecard for Q4: 16 stock

focus

hotspot

leisure time

focus

Wikipedia

APStockWASHINGTON—AfederaldistrictjudgeonMondaygrantedtheBidenadministration’srequesttodismissalawsu

WSS

Flu, Covid vaccination rates decline, new survey data show

Vaccine advisory panel ACIP left half staffed by HHS

Flu, Covid vaccination rates decline, new survey data show

What should King Charles tell the public about his cancer?

Private equity deals in Medicare Advantage declines

Key House Republican on health care plans exit from Congress

focus

fashion

focus

After affirmative action ruling, medical educators look to 'holistic review'

Lawsuit highlights wrinkle for disputes over surprise medical bills

How one medical school became remarkably diverse

What we owe ALS patients — and why one company fell short

What does generative AI mean for health care? We asked experts

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

At least 13 dead in Texas as scorching temps continue

CRISPR base editing slashes cholesterol levels in monkeys

Medicare details structure of new drug price negotiation program

Robert F. Kennedy is pitching centrism on health, even on abortion

focus

Stop Congress from blocking public access to science

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

The stability of $0 premiums in Medicare Advantage

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

How digital tools helped lower hypertension in marginalized patients

With Roe v Wade overturned, abortion providers work to adapt

hotspot

leisure time

focus

Wikipedia